NCT03558438 (FUNCFRAIL) is a clinical trial of No interventions in HIV Infections, sponsored by Fundacion SEIMC-GESIDA.

Who is sponsoring NCT03558438?

NCT03558438 is sponsored by Fundacion SEIMC-GESIDA.

What drugs are being tested in NCT03558438?

Interventions in NCT03558438: No interventions.

What condition does NCT03558438 study?

NCT03558438 studies HIV Infections, Frail Older Adults.

Is NCT03558438 still recruiting?

NCT03558438 is currently active, enrolled. Last updated 3 September 2024.

Last reviewed 2024-09-03 · How we verify

NCT03558438: FUNCFRAIL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function

Active, enrolled Last updated 3 September 2024

What this trial tests

trial testing No interventions in HIV Infections in 802 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

7 May 2018

Primary endpoint
31 May 2025

31 May 2025

Quick facts

Lead sponsor	Fundacion SEIMC-GESIDA
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	802
Start date	7 May 2018
Primary completion	31 May 2025
Estimated completion	31 May 2025
Sites	13 locations across Spain

Drugs / interventions tested

No interventions — full drug profile →

Conditions studied

HIV Infections — all drugs for HIV Infections →
Frail Older Adults — all drugs for Frail Older Adults →

Sponsor

Fundacion SEIMC-GESIDA — full company profile →

Who can join

50 and older, any sex, with HIV Infections or Frail Older Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It's a prospective observational study to assess frailty and physical function

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV.
Brañas F, Torralba M, Antela A, Vergas J, et al · · 2023 · cited 26× · PMID 36597036 · DOI 10.1186/s12877-022-03719-8

Verify or expand the search:

Other trials of No interventions

Trials testing the same drug.

NCT07497815 — Artificial Intelligence-assisted Diagnosis in Ophthalmology · not yet recruiting
NCT07509632 — Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning · active not recruiting
NCT07307040 — Precision Diabetes Management: Integrated East-West Approach · not yet recruiting
NCT07276945 — Individualized Early Diagnosis and Treatment System of Gestational Diabetes Mellitus (GDM) Based on New Continuous Gluco · not yet recruiting
NCT06999681 — Postoperative Arrhythmia and Preoperative Cardiac Function · not yet recruiting

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting

Other Fundacion SEIMC-GESIDA trials

Trials by the same sponsor.

NCT05898841 — Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patien · Phase 4 · completed
NCT05549180 — Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV · Phase 4 · completed
NCT05405751 — Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excl · Phase 4 · completed
NCT04880785 — Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine · Phase 2 · completed
NCT04884139 — DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03558438 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundacion SEIMC-GESIDA
Last refreshed: 3 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03558438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing